Search

Your search keyword '"Rubino, Paolo"' showing total 10 results
Start Over Author "Rubino, Paolo" Journal eurointervention
10 results on '"Rubino, Paolo"'

1. Impact on outcome of different types of carotid stent: results from the European Registry of Carotid Artery Stenting

Author

Stabile, Eugenio, primary, Giugliano, Giuseppe, additional, Cremonesi, Alberto, additional, Bosiers, Marc, additional, Reimers, Bernhard, additional, Setacci, Carlo, additional, Cao, Piergiorgio, additional, Schmidt, Andrej, additional, Sievert, Horst, additional, Peeters, Patrick, additional, Nikas, Dimitrios, additional, Sannino, Anna, additional, de Donato, Gianmarco, additional, Parlani, Giambattista, additional, Castriota, Fausto, additional, Hornung, Marius, additional, Rubino, Paolo, additional, Esposito, Giovanni, additional, and Tesorio, Tullio, additional

Published
2016
Full Text
View/download PDF

3. Simplifying clinical risk prediction for percutaneous coronary intervention of bifurcation lesions: the case for the ACEF (age, creatinine, ejection fraction) score

Author

Biondi-Zoccai, Giuseppe, primary, Romagnoli, Enrico, additional, Castagno, Davide, additional, Sheiban, Imad, additional, De Servi, Stefano, additional, Tamburino, Corrado, additional, Colombo, Antonio, additional, Burzotta, Francesco, additional, Presbitero, Patrizia, additional, Bolognese, Leonardo, additional, Paloscia, Leonardo, additional, Rubino, Paolo, additional, Sardella, Gennaro, additional, Briguori, Carlo, additional, Niccoli, Luigi, additional, Franco, Gianfranco, additional, Di Girolamo, Domenico, additional, Piatti, Luigi, additional, Greco, Cesare, additional, Petronio, A. Sonia, additional, Loi, Bruno, additional, Benassi, Alberto, additional, Patti, Aldo, additional, Gaspardone, Achille, additional, Frati, Giacomo, additional, and Sangiorgi, Giuseppe, additional

Published
2012
Full Text
View/download PDF

4. Procedural and early clinical outcomes of patients with de novo coronary bifurcation lesions treated with the novel Nile PAX dedicated bifurcation polymer-free paclitaxel coated stents: results from the prospective, multicentre, non-randomised BIPAX clinical trial

Author

Costa, Ricardo A., primary, Abizaid, Alexandre, additional, Abizaid, Andrea S., additional, Garcia del Blanco, Bruno, additional, Berland, Jacques, additional, Petrov, Ivo, additional, Brenot, Philippe, additional, van Guens, Robert-Jan, additional, Royer, Thierry, additional, Rubino, Paolo, additional, Lesiak, Maciej, additional, and Fajadet, Jean, additional

Published
2012
Full Text
View/download PDF

7. Acute left main obstructions following TAVI

Author

Stabile, Eugenio, primary, Sorropago, Giovanni, additional, Cioppa, Angelo, additional, Cota, Linda, additional, Agrusta, Marco, additional, Lucchetti, Vincenzo, additional, and Rubino, Paolo, additional

Published
2010
Full Text
View/download PDF

8. Elective implantation of sirolimus-eluting stents for bifurcated and non-bifurcated unprotected left main coronary artery lesions: clinical outcomes at one year

Author

Barragan, Paul, primary, Fajadet, Jean, additional, Sheiban, Imad, additional, Serruys, Patrick, additional, Colombo, Antonio, additional, Seabra-Gomes, Ricardo, additional, Goy, Jean-Jacques, additional, Cook, Stéphane, additional, Rubino, Paolo, additional, and Lefèvre, Thierry, additional

Published
2008
Full Text
View/download PDF

9. Use of endovascular clamping as neuroprotection during carotid stenting in the presence of a critical ipsilateral stenosis of the external carotid artery

Author

Stabile, Eugenio, primary, Sorropago, Giovanni, additional, Tesorio, Tullio, additional, Salemme, Luigi, additional, Ambrosini, Vittorio, additional, Cioppa, Angelo, additional, Popusoi, Gregory, additional, Nammas, Wail, additional, Biamino, Giancarlo, additional, and Rubino, Paolo, additional

Published
2008
Full Text
View/download PDF

10. Impact on outcome of different types of carotid stent: results from the European Registry of Carotid Artery Stenting

Author

Gianmarco de Donato, Andrej Schmidt, Piergiorgio Cao, Paolo Rubino, Horst Sievert, Marc Bosiers, Anna Sannino, Patrick Peeters, Giovanni Esposito, Bernhard Reimers, Eugenio Stabile, Marius Hornung, Giambattista Parlani, Carlo Setacci, Giuseppe Giugliano, Alberto Cremonesi, Fausto Castriota, Tullio Tesorio, Dimitrios Nikas, Stabile, Eugenio, Giugliano, Giuseppe, Cremonesi, Alberto, Bosiers, Marc, Reimers, Bernhard, Setacci, Carlo, Cao, Piergiorgio, Schmidt, Andrej, Sievert, Horst, Peeters, Patrick, Nikas, Dimitrio, Sannino, Anna, De Donato, Gianmarco, Parlani, Giambattista, Castriota, Fausto, Hornung, Mariu, Rubino, Paolo, Esposito, Giovanni, and Tesorio, Tullio

Subjects
Carotid Artery Diseases, Male, medicine.medical_specialty, Time Factors, medicine.medical_treatment, Carotid arteries, Population, 030204 cardiovascular system & hematology, Prosthesis Design, Risk Assessment, Stroke risk, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Angioplasty, 80 and over, Stent, medicine, Humans, Carotid Stenosis, Registries, cardiovascular diseases, education, Stroke, Aged, Aged, 80 and over, education.field_of_study, business.industry, Mortality rate, Carotid arterie, Middle Aged, medicine.disease, Stents, Female, Treatment Outcome, Cardiology and Cardiovascular Medicine, Surgery, business, 030217 neurology & neurosurgery, Carotid stent
Abstract

AIMS: Conflicting data exist on the impact on outcome of the use of different stent types during carotid artery stenting (CAS). The aim of this study was to evaluate clinical outcomes according to different carotid stent design among the population of the European Registry of Carotid Artery Stenting (ERCAS). METHODS AND RESULTS: The present study was conducted in 1,604 patients who underwent neuroprotected CAS in ERCAS. All types of commercially available carotid stent were used. Open-cell design stents were classified according to free cell area into 7.5 mm2. A total of 713 closed-cell, 456 hybrid-cell, 238 7.5 mm2 open-cell stents were implanted. Overall, the 30-day stroke and death rate was 1.37%. At 30 days, 19 strokes occurred (1.18%): eight in the group of patients treated with a closed-cell (1.12%), two in those with a hybrid-cell (0.44%), three in those with a 7.5 mm2 open-cell stent (3.05%) (p=0.045). CONCLUSIONS: Data of the present study suggest that, in the setting of neuroprotected CAS performed in high-volume centres by properly trained operators, the use of an open-cell design stent with a free cell area >7.5 mm2 may be associated with an increased 30-day stroke risk.

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results